BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 28212825)

  • 1. Inhibition of ubiquitin proteasome function prevents monocrotaline-induced pulmonary arterial remodeling.
    Zhu Y; Wu Y; Shi W; Wang J; Yan X; Wang Q; Liu Y; Yang L; Gao L; Li M
    Life Sci; 2017 Mar; 173():36-42. PubMed ID: 28212825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Siah2 ubiquitin ligase ameliorates monocrotaline-induced pulmonary arterial remodeling through inactivation of YAP.
    Wang Q; Shi W; Zhang Q; Feng W; Wang J; Zhai C; Yan X; Li M
    Life Sci; 2020 Feb; 242():117159. PubMed ID: 31837334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation.
    Shi W; Zhai C; Feng W; Wang J; Zhu Y; Li S; Wang Q; Zhang Q; Yan X; Chai L; Liu P; Chen Y; Li M
    Life Sci; 2018 Oct; 210():140-149. PubMed ID: 30179628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.
    Zhai C; Shi W; Feng W; Zhu Y; Wang J; Li S; Yan X; Wang Q; Zhang Q; Chai L; Li C; Liu P; Li M
    Life Sci; 2018 Sep; 208():87-95. PubMed ID: 30009823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
    J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvianolic acid A attenuates vascular remodeling in a pulmonary arterial hypertension rat model.
    Chen YC; Yuan TY; Zhang HF; Wang DS; Yan Y; Niu ZR; Lin YH; Fang LH; Du GH
    Acta Pharmacol Sin; 2016 Jun; 37(6):772-82. PubMed ID: 27180980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-Mediated FAK Phosphorylation.
    Zhai C; Zhang N; Wang J; Cao M; Luan J; Liu H; Zhang Q; Zhu Y; Xue Y; Li S
    Lung; 2022 Oct; 200(5):619-631. PubMed ID: 36107242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib alleviates experimental pulmonary arterial hypertension.
    Kim SY; Lee JH; Huh JW; Kim HJ; Park MK; Ro JY; Oh YM; Lee SD; Lee YS
    Am J Respir Cell Mol Biol; 2012 Nov; 47(5):698-708. PubMed ID: 22842494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ang-(1-7) might prevent the development of monocrotaline induced pulmonary arterial hypertension in rats.
    Chen L; Xiao J; Li Y; Ma H
    Eur Rev Med Pharmacol Sci; 2011 Jan; 15(1):1-7. PubMed ID: 21381494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
    Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
    Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a.
    Li F; Wang D; Wang H; Chen L; Sun X; Wan Y
    Respir Res; 2021 Aug; 22(1):239. PubMed ID: 34465322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway.
    Gao H; Cheng Y; Zong L; Huang L; Qiao C; Li W; Gong B; Hu J; Liu H; Wang X; Zhao C
    Clin Exp Hypertens; 2017; 39(1):34-41. PubMed ID: 28055284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
    Mei Y; Jin H; Tian W; Wang H; Wang H; Zhao Y; Zhang Z; Meng F
    Pulm Pharmacol Ther; 2011 Aug; 24(4):386-93. PubMed ID: 21396478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Aminosalicylic Acid Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats by Increasing the Expression of Nur77.
    Sun LY; Cai ZY; Pu J; Li J; Shen JY; Yang CD; He B
    Inflammation; 2017 Jun; 40(3):806-817. PubMed ID: 28213866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
    Lee JH; Park BK; Oh KS; Yi KY; Lim CJ; Seo HW; Lee BH
    Int Immunopharmacol; 2016 Nov; 40():196-202. PubMed ID: 27611861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydromyricetin prevents monocrotaline-induced pulmonary arterial hypertension in rats.
    Li Q; Wang J; Zhu X; Zeng Z; Wu X; Xu Y; Xie J; Yu J
    Biomed Pharmacother; 2017 Dec; 96():825-833. PubMed ID: 29078260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grape seed proanthocyanidin reverses pulmonary vascular remodeling in monocrotaline-induced pulmonary arterial hypertension by down-regulating HSP70.
    Chen F; Wang H; Yan J; Lai J; Cai S; Yuan L; Zheng S
    Biomed Pharmacother; 2018 May; 101():123-128. PubMed ID: 29482057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum-glucocorticoid regulated kinase 1 regulates macrophage recruitment and activation contributing to monocrotaline-induced pulmonary arterial hypertension.
    Xi X; Liu S; Shi H; Yang M; Qi Y; Wang J; Du J
    Cardiovasc Toxicol; 2014 Dec; 14(4):368-78. PubMed ID: 24825325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.